Artificial Saliva Market Report 2026

The artificial saliva market size has grown rapidly in recent years. It will grow from $2.21 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing prevalence of dry mouth conditions, growing use of medications causing xerostomia, expansion of cancer radiation therapies, rising awareness of oral health management, availability of over-the-counter saliva substitutes.

The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand from aging populations, rising focus on quality-of-life improvement therapies, expansion of pediatric-friendly formulations, growing innovation in bio-mimetic saliva products, increasing distribution through healthcare and retail channels. Major trends in the forecast period include increasing demand for xerostomia management products, rising development of alcohol-free oral formulations, growing focus on patient-friendly dosage forms, expansion of ready-to-use artificial saliva products, enhanced emphasis on oral comfort and hydration.

The increasing prevalence of dry mouth syndrome is anticipated to drive the growth of the artificial saliva market in the coming years. Dry mouth syndrome, also referred to as xerostomia, is a condition marked by a persistent sensation of dryness in the mouth. Its prevalence has risen partly due to an aging population and the widespread use of medications and over-the-counter drugs that can induce xerostomia. Artificial saliva helps moisten oral tissues, alleviating the dry, sticky feeling commonly associated with the condition. For example, in 2025, according to PubMed, the US-based National Institutes of Health reported that the pooled prevalence of xerostomia was 38% (95% CI: 22-57%). Consequently, the growing occurrence of dry mouth syndrome is fueling the expansion of the artificial saliva market.

Key companies in the artificial saliva market are concentrating on creating innovative solutions, such as poly(hydroxyethyl methacrylate) (pHEMA)-based in-mouth hydrogels that provide sustained moisture release for individuals with xerostomia. A pHEMA hydrogel is a biocompatible polymer matrix that absorbs synthetic saliva, swells significantly, and gradually releases moisture, unlike traditional artificial saliva sprays, which offer only short-term lubrication and require frequent reapplication. For instance, in August 2025, a US-based research team led by Debnath, Malandraki, and Boudouris developed a pHEMA artificial-saliva reservoir hydrogel intended for intraoral placement. The hydrogel can expand up to four times its dry volume, store saliva substitute solutions, release moisture gradually over several hours, and maintain performance across multiple swelling-release cycles. It also showed strong biocompatibility and provided more consistent lubrication, presenting a promising next-generation alternative for managing chronic dry mouth.

In March 2023, Hologram Sciences, a US-based health tech company, partnered with Haleon to develop personalized wellness products and address consumer health concerns. This strategic collaboration aims to meet unmet consumer needs in the United States using Haleon's established brands and to create new supplement concepts offering comprehensive, science-backed, personalized solutions. Haleon, a UK-based consumer healthcare company, provides innovative, science-backed health solutions, including artificial saliva products that alleviate dry mouth and support oral health.

Major companies operating in the artificial saliva market are Pfizer Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Cipla Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Recordati S.p.A., Mission Pharmacal Company, DENTAID S.L., Forward Science Holdings LLC, Saliwell Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Johnson & Johnson, Colgate-Palmolive Company, Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Thornton & Ross Ltd., Roquette Frères.

North America was the largest region in the artificial saliva market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial saliva market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the artificial saliva market by increasing costs of imported pharmaceutical ingredients, thickening agents, packaging materials, and processing equipment used in sprays, gels, and oral solutions. Manufacturers in North America and Europe are most affected due to reliance on imported excipients, while Asia-Pacific faces cost pressure on finished product exports. These tariffs are increasing production costs and retail prices. However, they are also encouraging local sourcing of raw materials and regional manufacturing of oral care therapeutics.

The artificial saliva market research report is one of a series of new reports that provides artificial saliva market statistics, including artificial saliva industry global market size, regional shares, competitors with a artificial saliva market share, detailed artificial saliva market segments, market trends and opportunities, and any further data you may need to thrive in the artificial saliva industry. This artificial saliva market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial saliva is a synthetic product created to replicate the properties and functions of natural saliva. It is used to alleviate dryness in the mouth (xerostomia) caused by various conditions such as Sjögren's syndrome, radiation therapy for cancer, or certain medications. Artificial saliva helps to moisten and lubricate the mouth, assists in chewing and swallowing, and can enhance overall oral comfort.

The main types of products in the artificial saliva market include oral spray, oral solution, oral liquid, dissolving tablets, gel, and powder. Oral spray is a formulation in spray form, designed to temporarily relieve the symptoms of dry mouth (xerostomia) by providing lubrication and moisture to the oral cavity. The distribution channels include supermarkets, hypermarkets, and others, while the end-users consist of both adults and children.

The artificial saliva market consists of sales of sprays, gels, and lozenges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.